1
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Investigation of adverse reactions in healthcare personnel working in Level 3 barrier protection PPE to treat COVID-19

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose of the study

          The aim of our study was to investigate potential adverse reactions in healthcare professionals working in Level 3 barrier protection personal protective equipment (L3PPE) to treat patients with COVID-19.

          Study design

          By using a convenience sampling approach, 129 out of 205 randomly selected healthcare professionals from the First Affiliated Hospital of Zhejiang University School of Medicine were invited to take part in a WeChat messaging app survey, Questionnaire Star, via a survey link. Healthcare personnel details were collected, including profession, years of professional experience and adverse reactions while wearing L3PPE. Survey results were divided by profession and years of professional experience; differences in adverse reactions were compared.

          Results

          Among the 129 healthcare professionals surveyed, 21 (16.28%) were doctors and 108 (83.72%) were nurses. A total of 122 (94.57%) healthcare professionals experienced discomfort while wearing L3PPE to treat patients with COVID-19. The main reasons for adverse reactions and discomfort include varying degrees of adverse skin reactions, respiratory difficulties, heat stress, dizziness and nausea. Doctors had a lower incidence of rashes (χ 2=4.519, p=0.034) and dizziness (χ 2=4.123, p=0.042) when compared with nurses. Junior (8.5 years of experience or fewer) healthcare personnel also experienced a higher rate of heat stress when compared with senior personnel (more than 8.5 years greater) (χ 2=5.228, p=0.022).

          Conclusion

          More attention should be offered to healthcare personnel wearing L3PPE to treat patients with COVID-19 because they are susceptible to developing adverse reactions.

          Related collections

          Most cited references9

          • Record: found
          • Abstract: found
          • Article: not found

          [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].

          (2020)
          Objective: An outbreak of 2019 novel coronavirus diseases (COVID-19) in Wuhan, China has spread quickly nationwide. Here, we report results of a descriptive, exploratory analysis of all cases diagnosed as of February 11, 2020. Methods: All COVID-19 cases reported through February 11, 2020 were extracted from China's Infectious Disease Information System. Analyses included: 1) summary of patient characteristics; 2) examination of age distributions and sex ratios; 3) calculation of case fatality and mortality rates; 4) geo-temporal analysis of viral spread; 5) epidemiological curve construction; and 6) subgroup analysis. Results: A total of 72 314 patient records-44 672 (61.8%) confirmed cases, 16 186 (22.4%) suspected cases, 10567 (14.6%) clinical diagnosed cases (Hubei only), and 889 asymptomatic cases (1.2%)-contributed data for the analysis. Among confirmed cases, most were aged 30-79 years (86.6%), diagnosed in Hubei (74.7%), and considered mild (80.9%). A total of 1 023 deaths occurred among confirmed cases for an overall case-fatality rate of 2.3%. The COVID-19 spread outward from Hubei sometime after December 2019 and by February 11, 2020, 1 386 counties across all 31 provinces were affected. The epidemic curve of onset of symptoms peaked in January 23-26, then began to decline leading up to February 11. A total of 1 716 health workers have become infected and 5 have died (0.3%). Conclusions: The COVID-19 epidemic has spread very quickly. It only took 30 days to expand from Hubei to the rest of Mainland China. With many people returning from a long holiday, China needs to prepare for the possible rebound of the epidemic.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis

            Introduction An epidemic of Coronavirus Disease 2019 (COVID-19) began in December 2019 in China leading to a Public Health Emergency of International Concern (PHEIC). Clinical, laboratory, and imaging features have been partially characterized in some observational studies. No systematic reviews on COVID-19 have been published to date. Methods We performed a systematic literature review with meta-analysis, using three databases to assess clinical, laboratory, imaging features, and outcomes of COVID-19 confirmed cases. Observational studies and also case reports, were included, and analyzed separately. We performed a random-effects model meta-analysis to calculate pooled prevalences and 95% confidence intervals (95%CI). Results 660 articles were retrieved for the time frame (1/1/2020-2/23/2020). After screening, 27 articles were selected for full-text assessment, 19 being finally included for qualitative and quantitative analyses. Additionally, 39 case report articles were included and analyzed separately. For 656 patients, fever (88.7%, 95%CI 84.5–92.9%), cough (57.6%, 95%CI 40.8–74.4%) and dyspnea (45.6%, 95%CI 10.9–80.4%) were the most prevalent manifestations. Among the patients, 20.3% (95%CI 10.0–30.6%) required intensive care unit (ICU), 32.8% presented with acute respiratory distress syndrome (ARDS) (95%CI 13.7–51.8), 6.2% (95%CI 3.1–9.3) with shock. Some 13.9% (95%CI 6.2–21.5%) of hospitalized patients had fatal outcomes (case fatality rate, CFR). Conclusion COVID-19 brings a huge burden to healthcare facilities, especially in patients with comorbidities. ICU was required for approximately 20% of polymorbid, COVID-19 infected patients and hospitalization was associated with a CFR of >13%. As this virus spreads globally, countries need to urgently prepare human resources, infrastructure and facilities to treat severe COVID-19.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Reasons for healthcare workers becoming infected with novel coronavirus disease 2019 (COVID-19) in China

              Sir, The outbreak of novel coronavirus disease 2019 (COVID-19) in mainland China has been declared as a public health emergency (PHE) by the World Health Organization (WHO) [1]. Globally, until February 28th, 2020, there have been reported 83,774 confirmed cases and 2867 deaths [2]. During the periods of outbreak of COVID-19 or other infectious diseases, implementation of infection prevention and control (IPC) is of great importance in healthcare settings, especially regarding personal protection of healthcare workers [3,4]. In order to contain the outbreak of COVID-19 in mainland China, the National Health Commission of the People's Republic of China (NHCPRC) has so far dispatched medical support teams (41,600 healthcare workers from 30 provinces and municipalities) to assist with medical treatment in Wuhan and Hubei provinces [5]. A survey by the Health Commission of Guangdong Province released information on the distribution of 2431 healthcare workers in the Guangdong medical support teams [6]. Nurses (∼60%) were the predominant healthcare workers in the teams, followed by clinicians (∼30%). Half of clinicians with job titles were deputy chief physician, and 25% specialized in respiratory and critical medicine [6]. It is worth mentioning that 5.8% (140/2431) healthcare workers worked on the outbreak of severe acute respiratory syndrome in 2003 [6]. Recently, Wu et al. have reported the problems relating to COVID-19 IPC in healthcare settings, highlighting the personal protection of healthcare workers [7]. However, at a press conference of the WHO–China Joint Mission on COVID-19, NHCPRC reported that up until February 24th 2055 healthcare workers (community/hospital-acquired not to be defined) had been confirmed infected with COVID-19, with 22 (1.1%) deaths [8]. Ninety percent of infected healthcare workers were from Hubei province, and most cases happened in late January. It is worth mentioning that the proportion of healthcare workers infected by COVID-19 (2.7%, 95% CI: 2.6–2.8) was significantly lower compared with healthcare workers infected by SARS (21.1%, 95% CI: 20.2–22.0). Therefore, the director of the National Hospital Infection Management and Quality Control Centre summarized some reasons for such a high number of infected healthcare workers during the beginning of the emergency outbreak [9]. First, inadequate personal protection of healthcare workers at the beginning of the epidemic was a central issue. In fact, they did not understand the pathogen well; and their awareness of personal protection was not strong enough. Therefore, the front-line healthcare workers did not implement the effective personal protection before conducting the treatment. Second, long-time exposure to large numbers of infected patients directly increased the risk of infection for healthcare workers. Also, pressure of treatment, work intensity, and lack of rest indirectly increased the probability of infection for healthcare workers. Third, shortage of personal protective equipment (PPE) was also a serious problem. First-level emergency responses have been initiated in various parts of the country, which has led to a rapid increase in the demand for PPE. This circumstance increased the risk of infection for healthcare workers due to lack of sufficient PPE. Fourth, the front-line healthcare workers (except infectious disease physicians) received inadequate training for IPC, leaving them with a lack of knowledge of IPC for respiratory-borne infectious diseases. After initiation of emergency responses, healthcare workers have not had enough time for systematic training and practice. Professional supervision and guidance, as well as monitoring mechanisms, were lacking. This situation further amplified the risk of infection for healthcare workers. Finally, international communities, especially in other low- and middle-income countries with potential COVID-19 outbreaks, should learn early how to protect their healthcare workers. Furthermore, the COVID-19 confirmed cases have been reported to have surged in South Korea, Japan, Italy, and Iran in the past few days [2]. The increase in awareness of personal protection, sufficient PPE, and proper preparedness and response would play an important role in lowering the risk of infection for healthcare workers. Conflict of interest statement None declared. Funding sources None.
                Bookmark

                Author and article information

                Journal
                Postgrad Med J
                Postgrad Med J
                postgradmedj
                pmj
                Postgraduate Medical Journal
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                0032-5473
                1469-0756
                June 2020
                18 June 2020
                : postgradmedj-2020-137854
                Affiliations
                [1 ]departmentDepartment of Respiratory Medicine, The First Affiliated Hospital of Zhejiang University School of Medicine , Hangzhou, China
                [2 ]departmentDepartment of Respiratory and Gastroenterology, The First Affiliated Hospital of Zhejiang University School of Medicine , Hangzhou, China
                [3 ]departmentDeparment of Orthopedics, The First Affiliated Hospital of Zhejiang University School of Medicine , Hangzhou, China
                Author notes
                Correspondence to Mrs Zhang-Hong Lv, Department of Respiratory Medicine, First Affiliated Hospital of Zhejiang University School of Medicine, #79, Qingchun Road, Hangzhou 310006, China; zylvzhanghong@ 123456163.com
                Author information
                http://orcid.org/0000-0003-0955-5435
                Article
                postgradmedj-2020-137854
                10.1136/postgradmedj-2020-137854
                7301344
                32554543
                59ce308b-8f1a-4cdb-8146-30e07b75fd04
                © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

                This article is made freely available for use in accordance with BMJ's website terms and conditions for the duration of the COVID-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

                History
                : 09 April 2020
                : 06 June 2020
                : 21 April 2020
                Categories
                Original Research
                2474
                Custom metadata
                free

                Medicine
                respiratory medicine (see thoracic medicine)
                Medicine
                respiratory medicine (see thoracic medicine)

                Comments

                Comment on this article